Objectives-This study was designed to measure the changes in brachial artery wall stiffness by shear wave elastography (SWE) and evaluate the accuracy of SWE changes for detection of endothelial dysfunction.
T he endothelium is the main regulator of vascular homeostasis. It maintains the balance between vasoconstriction and vasodilatation and proliferation of smooth muscle cells, and it provides a balance of inhibition and stimulation of thrombogenesis and fibrinolysis. 1, 2 The endothelium is a monocell layer that envelops the vessel, and its dysfunction is characterized by impairment and loss of these cells. Endothelial dysfunction is the first stage in atherosclerosis and is considered an early marker of it, before evidence of atherosclerotic plaque is shown on angiography or ultrasonography (US). 1 Flow-mediated dilatation is a useful method for establishing endothelial dysfunction. It is endothelium dependent, and it can be measured by US of the brachial artery. 3 Shear wave elastography (SWE) is a new US technique in which an acoustic pressure wave induces slow-moving lateral waves in the tissue, and it is known that shear waves travel faster in stiffer tissues. 4 In this study, we evaluated patients with both flowmediated dilatation and SWE properties. We wanted to see whether the change in elastographic values parallels flow-mediated dilatation. We also hypothesized that the use of SWE features, singly or in combination with other techniques as an adjunct to conventional angiography, would improve the accuracy of detecting endothelial dysfunction.
Materials and Methods
The local Ethics Committee approved this study, and written informed consent was obtained from all participants before inclusion in the study. Sixty-five participants, divided into 4 groups, were enrolled in the study. Group 1 was composed of 19 patients with atherosclerosis proven by coronary angiography. Group 2 was composed of 16 healthy young adults from hospital personnel. Group 3 was composed of 15 patients with cardiac risk factors, 5 of whom had a single risk factor (hypertension, hypercholesterolemia, smoking, diabetes mellitus, or family history), and 10 of whom had 2 or more risk factors. Group 4 was composed of 15 healthy older adults without risk factors between 50 and 60 years from hospital personnel. In the risk factor group, ischemic heart disease was excluded by coronary angiography. We excluded candidates taking angiotensin-converting enzyme inhibitors, nitrates, and antioxidants. Other vasodilating drugs were stopped 1 day before the measurements, and patients who smoked were not allowed to smoke for 12 hours before the examinations.
We measured flow-mediated dilatation and SWE parameters under the following conditions: The patients rested in a silent, dark room for longer than 20 minutes before the procedures. In the supine position, we noticed that the inspected brachial artery was not above the heart level. Generally, tests were done in the morning in terms of standardization. A cuff was placed on the forearm, distal to the brachial artery to be examined, and remained inflated for about 5 minutes. The participants fasted for about 5 to 6 hours before the examinations. They were not allowed to exercise for about 8 to 10 hours and not to drink beverages containing alcohol or caffeine. Patient medications were stopped 8 hours before the examinations. Menstruating women were examined between days 1 and 7 of their cycle. 5 In the supine position, longitudinal images of the brachial artery were taken with a high-resolution superficial US transducer (7-12 MHz; Aplio 500; Toshiba Medical Systems Co, Ltd, Tokyo, Japan) before the cuff was inflated. In a longitudinal view, the baseline diameter between the near and distant arterial walls and SWE values from the posterior wall were measured 3 cm proximal to the antecubital region from the brachial artery before and after cuff inflation. While measuring the SWE values, care was taken to ensure that the gel layer was left between the transducer and the skin to avoid compression. Then the cuff was placed 1 to 2 cm distal to the elbow and inflated 50 mm Hg above the systolic pressure for 5 minutes. Flow-mediated dilatation is commonly reported as the percentage of change from the baseline diameter. The glow-mediated dilatation response (percent) and elastographic changes (percent) were calculated. The maximal increase in diameter occurs 45 to 60 seconds after the release of the cuff, 3 so we performed flow-mediated dilatation measurements during that period (Figure 1 ). Immediately after flowmediated dilatation measurement, SWE measurement was performed.
The percentage of increase in the artery diameter before and after the cuff inflation was calculated. In addition, the SWE value from the posterior wall of the brachial artery after cuff inflation was measured, and the percentage of decrease was calculated after the cuff inflation compared to the preinflation measurement. The percentage of decrease in the SWE value was calculated by the following formula: (preinflation SWE speedpostinflation SWE speed)/preinflation SWE speed. When the SWE measurement was performed, the region of interest was drawn manually on the posterior wall of the artery in a way that the lumen or surrounding tissue would not enter ( Figure 2 ).
Shear wave elastographic measurements obtained from manually drawn regions of interest and flowmediated dilatation values were used for the statistical evaluation. The statistical analysis was performed with SPSS version 16.0 software (IBM Corporation, Armonk, NY). The Kolmogorov-Smirnov test was used to analyze the the normal distribution of data. The difference between atherosclerosis patients and other groups was examined by analysis of variance and a post hoc Bonferonni test for subgroup analyses. All measurements were expressed as means 6 2 SDs. P < .05 was considered statistically significant. The SWE cutoff value that maximized the accuracy to separate the group with risk factors (group 3) and the group with obvious atherosclerosis (group 1) from the other healthy groups (groups 2 and 4) was established on a receiver operating characteristic curve. The sensitivity and specificity based on SWE values were calculated.
Results
The ages of the 65 participants ranged from 25 to 86 years. The general characteristics of the participants are shown in Table 1 . We divided participants into 4 groups: patients with atherosclerosis proven by coronary angiography (group 1), healthy young adults with no risk factors (group 2), patients with cardiovascular risk factors (group 3), and healthy older adults with no risk factors (group 4). In group 1, the number of risk factors was 1.89 6 0.65; 47.4% of the patients were hypertensive; 78.9% were smokers, 42.1% were hyperlipidemic; 21.1% had diabetes mellitus; and 15.8% had a family history. In group 3, the number of risk factors was very close to that in group 1: 1.80 6 0.67; 46.7% of them were hypertensive; 53.3% were smokers; 33.3% were hyperlipidemic; 13.3% had diabetes mellitus; and 33.3% had a family history. The mean age for group 1 was 66.1 6 11.4 years (range 38-85 years); the mean age for group 2 was 28 6 3.8 years (range, 25-37 years); the mean age for group 3 was 60.4 6 10.8 years (range, 46-86 years); and the mean age for group 4 was 60.8 6 4.06 years (range, 49-77 years). The ages of groups 1, 3, and 4 were statistically similar; only group 2 was younger.
In the study, there were 2 groups of tests, including flow-mediated dilatation and SWE measurements. In the flow-mediated dilatation measurements (Table 1) ; the result for patients with atherosclerosis (group 1) was 3.81% 6 2.4%, whereas they were 8.54% 6 1.4% in group 2 (P < .001), 5.83% 6 0.7% in group 3 (P < .001 with respect to group 1; P < .001 with respect to group 2; P < .05 with respect to group 4), and 7.61% 6 1.4% in group 4. The flow-mediated dilatation change in group 1 was less than in the other groups (P < .01 for all comparisons in the Bonferonni post hoc analysis). Statistically, there was no difference between groups 2 and 4.
In SWE measurements, baseline SWE speed values were not statistically significant between groups 1 and 2. The SWE decreases for groups 1, 2, 3, and 4 were 7.8% 6 6.4%, 19.9% 6 6.3%, 9.8% 6 5.4%, and 16.3% 6 5.1%, respectively. Statistically, there was no difference between groups 1 and 3 and no difference between groups 2 and 4. Patients with known endothelial dysfunction (group 1) and those with risk factors (group 3) had significantly lower SWE changes than participants with no risk factors (groups 2 and 4).
The receiver operating characteristic curve for elastic dysfunction diagnosis based on SWE change values is shown in Figure 3 . The SWE change cutoff value to detect endothelial dysfunction that maximized the accuracy was 11.5%; the area under curve was 0.898; and sensitivity and specificity were 93% and 70%, respectively. In a Pearson correlation analysis, flow-mediated dilatation was significantly associated with the baseline diameter (P < .001) and SWE change (P < .001). A linear regression analysis was performed on the flowmediated dilatation changes and SWE speed changes, and they were highly correlated (P < .001). This result would suggest that the SWE speed could be used as a substitute for flow-mediated dilatation.
Discussion
In our study, flow-mediated dilatation values were significantly lower in patients with risk factors and known cardiovascular disease than in healthy participants without risk factors. Our main goal in this study was to determine whether there was a significant difference in SWE changes between patients with substantial risk factors compared to control groups, such as the difference in flow-mediated dilatation. According to the results we found, the change in elasticity in the patient group was statistically less than the changes in the control groups. This finding suggests that there may be elastic dysfunction in patients with endothelial dysfunction at the same time.
The early diagnosis of atherosclerosis and the search for prognostic markers for the appearance of coronary episodes constitute a very active research area, and endothelial dysfunction is the early key indicator of atherosclerosis. 6 There are many methods for evaluating endothelial dysfunction: measurement and comparison of the coronary artery diameter before and after acetylcholine infusion with conventional angiography, 7, 8 intravascular Doppler US of coronary arteries, and plethysmography of venous occlusion, and we also know that endothelial dysfunction is inversely proportional to the serum C-reactive protein level. 9 Flow-mediated dilatation is vasodilatation arising in the artery due to an increase in blood flow or a shear increase in the inner wall. Studies have shown that if the endothelium is intact, it produces a vasodilator agent called nitric oxide (NO), and NO antagonists decrease flow-mediated dilatation. [10] [11] [12] [13] [14] Flow-mediated dilatation is at least as effective as traditional risk factors in predicting cardiovascular disease in both asymptomatic patients and those with cardiovascular disease. 15 Studies are based on an evaluation of the brachial artery to show endothelial dysfunction in the coronary artery for flow-mediated dilatation measurement because studies have shown that the in vivo physiologic characteristics of the brachial artery are similar to those of the coronary arteries. 16 We also used brachial arteries to assess elastic dysfunction in the coronary arteries because of the similar physiologic properties. As we have already mentioned, the main reason for us to study the SWE change with flow-mediated dilatation here was to see whether SWE changes in elastic dysfunction parallel flow-mediated dilatation.
Shear wave elastography is a noninvasive method that has become popular recently and has been used in many areas, mainly thyroid and breast diseases. [17] [18] [19] It has also been used to evaluate vessel wall changes: namely, atherosclerosis plaque characterization. De Korte et al 20 conducted an in vitro experimental study. In that study, in a water tank with an intravascular US catheter, places with increased stiffness such as calcium deposits and plaques in the femoral artery yielded more red in the color scale on strain elastography, and they obtained useful information about the mechanical properties of the artery. In another in vitro study, Ramnarine et al 21 measured the hardness of plaques under steady and pulsatile flow using the SWE method with phantoms mimicking soft and hard carotid plaques. Demidova et al 22 presented a poster at the European Congress of Radiology in 2013. Their study included patients with a new diagnosis of hypertension without atherosclerosis and a control group without atherosclerosis or risk factors. The elastographic method they used was strain elastography, which is not quantitative. They found that the normal endothelium has uniform green, yellow, and red areas, reflecting a soft elastic structure, and they reported that color does not change on the color map in response to reactive hyperemia. They also claimed that endothelial dysfunction is characterized by initial irregular coloring of the endothelium, which represents soft and tight elastic structures, and it changes on the color map after reactive hyperemia. 22 In our study, although we obtained quantitative values with SWE, the statistical analysis and the study method were designed on the basis of the percentage of change before and after cuff inflation, not on the constant average of the measurements. Shear wave elastography is considered less operator dependent than strain elastography and to have better reproducibility than earlier US elastographic techniques that were based on operator compression of the tissue to induce transient stress and assess tissue deformation. 23 When the results of our study were examined, flowmediated dilatation values were statistically significantly lower in the atherosclerosis group than the healthy groups. Patients with known atherosclerosis represented apparent elastic dysfunction; patients with risk factors represented partial elastic dysfunction; and healthy young adults and the older group with no risk factors represented the least likely groups to have elastic dysfunction. When assessed in terms of baseline SWE values (Table  1) , there was no significant difference between the healthy groups and the group with known atherosclerosis (group 1). That finding made us think that looking at the percentage of the SWE change before and after cuff inflation would be more useful in determining elastic dysfunction versus the self-worth of the baseline elasticity value. Changes in SWE values were lower in groups with endothelial dysfunction than in the other groups. Although there is no definite information about this finding, we think that this change may be related to a loss of smooth muscle tone, which is less than that in individuals without endothelial dysfunction. Studies have shown that NO release is decreased in arteries with endothelial dysfunction. 24 When NO is synthesized in normal arteries, it diffuses across the endothelial cells into the adjacent smooth muscle and decreases smooth muscle tension. 24 In some studies, [25] [26] [27] it was shown that arterial stiffness was associated with aging, smoking, hypertension, and dyslipidemia. It can occur as a result of a reduction in NO, loss of smooth muscle tone, degeneration of elastin fibers, and increased collagen deposition in the vascular wall.
Our study has some limitations. We did not evaluate the repeatability of the technique because we did not perform an interobserver variability analysis. Another limitation was that we did not study parameters such as high-density lipoprotein and low-density lipoprotein. Therefore, the relationship between high-density lipoprotein and endothelial function could not be evaluated. This factor may be important, but the main focus of this study was to measure the elasticity of the brachial artery with SWE, a newly used method, and to calculate the elasticity change. Another issue was that we did not do electrocardiographic gating when measuring flowmediated dilatation. Since electrocardiographic gating was not performed, we tried to measure the artery pulse in the widest state during end diastole.
In conclusion, this preliminary study showed that the change in elasticity values before and after cuff inflation in the brachial artery wall of patients with endothelial dysfunction was lower than the changes in the control groups. Despite the challenges and limitations, we have described the feasibility of SWE for quantification of elastic dysfunction in the artery wall. The SWE technique can be used in conjunction with other methods to provide useful information about the mechanical properties of the vessel, although further research is needed.
